Table S5 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Q: What type of study is this?

This is a Quantitative Study study.

John D. Powderly; Martina Imbimbo; Antoîne Italiano; Patricia Martín-Romano; Meredith McKean; Teresa Macarulla; Eduardo Castañón Álvarez; Benedito A. Carneiro; Raymond Mager; Vicky Barnhart; Steven Eck; Elina Murtomaki; Arsène‐Bienvenu Loembé; Yun He; Zachary A. Cooper; Eric Tu; Chunling Fan; Agnes Boyer Chamard; Carine Paturel; Paula G. Fraenkel; Antoine Hollebecque

doi:10.1158/2767-9764.30177688

Key Points

IPH5201 shows notable immunogenicity in advanced solid tumors, revealing important insights for treatment effectiveness.
The analysis focuses on the immunogenic response associated with IPH5201, and its combination with durvalumab suggests enhanced therapeutic potential.
Methodologically, results are drawn from immunogenicity assessments conducted for anti-CD39 mAb in the context of advanced solid tumors.
These findings highlight the significance of understanding immune responses to improve treatment strategies for patients with advanced solid tumors.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Implication

Assessment highlights the immunogenicity of anti-CD39 mAb IPH5201 in advanced solid tumors, suggesting potential accuracy of this combination treatment.

Abstract

Summary of immunogenicity of IPH5201.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Powderly et al. (2025) studied this question.

synapsesocial.com/papers/68d4725631b076d99fa6b16f https://doi.org/10.1158/2767-9764.30177688

View Full Paper

Ask AI

Bookmark

Share

Table S5 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Table S5 from IPH5201, an Anti-CD39 mAb, as Monotherapy or in Combination with Durvalumab in Advanced Solid Tumors

Key Points

No abstract yet

Implication

Abstract

Discussion

Cite This Study

Keep reading

Keep reading